A meaningful share of England's specialist prescribing never touches a high-street pharmacy. Biologic infusions for rheumatoid arthritis, factor concentrates for haemophilia, growth hormone for paediatric endocrine clinics and enzyme-replacement therapy for rare metabolic conditions are delivered — often literally to the patient's kitchen table — by homecare medicines providers.

These providers sit outside the world most patients know. Their dispensaries do not have shop fronts. Their vacancies rarely appear on the public pharmacy jobs feeds that PharmSee tracks. For patients who have just been transferred onto homecare, or for community pharmacists asked "who is Sciensus?" at the counter, this guide explains what the sector looks like in 2026.

What is a homecare medicines provider

A homecare provider is a licensed pharmacy service that dispenses and delivers medicines directly to a patient's home, often including clinical support such as nurse administration or infusion training. The patient still has an NHS prescription; the service is commissioned by the trust or specialist centre rather than collected in person.

The Royal Pharmaceutical Society describes homecare as "the supply of ongoing medicines and, where appropriate, clinical care, directly to the patient's home or other agreed location with their consent". Contracts sit between individual NHS trusts, specialist commissioners and the homecare providers.

The main providers

The UK homecare market is dominated by a small number of providers. The table below summarises the largest by estimated patient volume in 2026, based on public company information and NHS framework appointments. Figures should be read as directional; the sector does not publish unified patient-count data.

Each provider works under a dispensing pharmacist superintendent and is regulated by the General Pharmaceutical Council in the same way as any other UK pharmacy. Clinical governance, patient consent and incident reporting flow through standard NHS structures, but operations are geographically centralised — often a single UK dispensary serves tens of thousands of patients.

What the service typically includes

Homecare is more than delivery. The standard package includes:

• Medicine supply — prescription dispensed to the registered address or clinic.
• Cold-chain handling — validated temperature monitoring for biologics, factor concentrates and advanced therapies.
• Clinical support — telephone nurse line, administration training, adherence monitoring.
• Nurse visits — for injectable biologics, some infusions and training.
• Sharps disposal and consumables — needles, infusion sets, dressings.
• Reordering workflow — typically 28-day or 84-day cycles, triggered by the patient or an automated reminder.

Patients remain under the care of their referring specialist centre; the provider is a delivery and dispensing partner, not the prescriber.

Why these providers do not appear on most pharmacy job boards

PharmSee tracks live vacancies from eleven major pharmacy job sources: Boots, NHS Jobs, Cohens, Superdrug, Tesco, Asda, Morrisons, Rowlands, Weldricks, Day Lewis and Well. In the most recent PharmSee snapshot, these sources carried 1,742 active pharmacy vacancies.

Sciensus, HealthNet, Alcura, Lloyds Clinical, Polar Speed and PharmaXO do not appear on this feed. That is a structural feature of the market, not a PharmSee gap: homecare providers recruit through their own careers sites, specialist recruiters and professional networks rather than the retail and NHS job boards most pharmacists watch. A community pharmacist looking to move into homecare will usually need to approach the providers directly.

PharmSee's live vacancy dashboard at /app/jobs therefore understates the total UK pharmacist employment market by the share represented by homecare — plausibly several thousand additional roles across pharmacists, technicians, dispensers and delivery drivers, though a precise figure is not published.

What this means for patients

If a patient is transferred to homecare, the community pharmacy will stop seeing the hospital-only medicine on their record. That can create safety gaps: a GP prescribing a new antibiotic may not see that the patient is on adalimumab, or the pharmacy may not know to counsel on interactions. Patients should be encouraged to:

• Keep a current medicines list that includes homecare items.
• Tell their GP and community pharmacy which provider they use and what medicine they receive.
• Carry written confirmation of any cold-chain or specialist product.

What this means for pharmacists considering a career move

Homecare employs substantial numbers of pharmacists in clinical governance, dispensary oversight and patient services. Salary bands tend to sit between community and NHS ranges, with more structured shift patterns and fewer weekend commitments. Career progression typically runs through lead pharmacist and superintendent roles.

The absence of these vacancies from public job feeds means the hiring market is quieter than the headline figures suggest. PharmSee's broader /salary dashboard can be used as a reference for benchmarking when a homecare role is offered, but the specific band for a given homecare provider will need to come from the offer itself.

Caveats

This overview is based on publicly available information about UK homecare providers as of April 2026. Ownership structures, therapeutic specialisms and NHS contract positions can change with each framework renewal. Patients with clinical concerns about their homecare should contact their treating specialist centre or the provider's patient support line.

Sources

• Royal Pharmaceutical Society, Homecare medicines services guidance.
• NHS England, Specialised Services commissioning framework.
• Company publications of Sciensus, HealthNet, Alcura, Lloyds Clinical and PharmaXO (publicly accessible corporate websites, accessed April 2026).